The Response – The Ability – The ResponseAbility

Author Archive

Custom Healthcare has disposed of it’s investment in the newly completed solid dose manufacturing site of Shandong Tripardus Pharmaceuticals Ltd in Jinan, Shandong Province, NE China.

The decision was taken on commercial grounds after careful consideration of needs of the UK business and as a result of the increasing market demand for local manufacture within the UK/EU.

As a result of these Custom Pharmaceuticals Ltd in the UK is recruiting additional staff and planning for significant inward investment to create new capacity for manufacture at its UK sites

Watch the news item below from BBC South East News for an interview with Nigel Richardson.